Sponsor Pipeline

Primmune Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT07565285
The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage…		 Recruitment opened
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07565285 The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage… Melanoma Stage III Recruiting
Disease Areas
Melanoma (1)
Get alerts when Primmune Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free